Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

The Biology Behind

  • The Biology Behind
    Immunogenic Cell Death and Cross-Priming Are Reaching the Clinical Immunotherapy Arena
    Ignacio Melero, Ainhoa Arina, Oihana Murillo, Juan Dubrot, Carlos Alfaro, Jose L. Pérez-Gracia, Maurizio Bendandi and Sandra Hervás-Stubbs
    Clin Cancer Res April 15 2006 12 (8) 2385-2389; DOI:10.1158/1078-0432.CCR-06-0314

Molecular Pathways

  • Molecular Pathways
    Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Pathway and Its Therapeutic Implications
    Elisabeth G.E. de Vries, Jourik A. Gietema and Steven de Jong
    Clin Cancer Res April 15 2006 12 (8) 2390-2393; DOI:10.1158/1078-0432.CCR-06-0352

Human Cancer Biology

  • Human Cancer Biology
    Alterations in the T-Cell Receptor Variable β Gene–Restricted Profile of CD8+ T Lymphocytes in the Peripheral Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck
    Andreas E. Albers, Carmen Visus, Takashi Tsukishiro, Robert L. Ferris, William Gooding, Theresa L. Whiteside and Albert B. De Leo
    Clin Cancer Res April 15 2006 12 (8) 2394-2403; DOI:10.1158/1078-0432.CCR-05-1818

  • Human Cancer Biology
    Transcriptional and Posttranscriptional Down-Regulation of the Imprinted Tumor Suppressor Gene ARHI (DRAS3) in Ovarian Cancer
    Zhen Lu, Robert Z. Luo, Hongqi Peng, Daniel G. Rosen, E. Neely Atkinson, Carla Warneke, Maosheng Huang, Arata Nishmoto, Jinsong Liu, Warren S-L. Liao, Yinhua Yu and Robert C. Bast Jr.
    Clin Cancer Res April 15 2006 12 (8) 2404-2413; DOI:10.1158/1078-0432.CCR-05-1036

  • Human Cancer Biology
    Molecular Evidence for the Same Clonal Origin of Multifocal Papillary Thyroid Carcinomas
    Ryan P. McCarthy, Mingsheng Wang, Timothy D. Jones, Randall W. Strate and Liang Cheng
    Clin Cancer Res April 15 2006 12 (8) 2414-2418; DOI:10.1158/1078-0432.CCR-05-2818

  • Human Cancer Biology
    Establishment of Perineural Invasion Models and Analysis of Gene Expression Revealed an Invariant Chain (CD74) as a Possible Molecule Involved in Perineural Invasion in Pancreatic Cancer
    Norimasa Koide, Taketo Yamada, Rie Shibata, Taisuke Mori, Mariko Fukuma, Ken Yamazaki, Koichi Aiura, Motohide Shimazu, Setsuo Hirohashi, Yuji Nimura and Michiie Sakamoto
    Clin Cancer Res April 15 2006 12 (8) 2419-2426; DOI:10.1158/1078-0432.CCR-05-1852

  • Human Cancer Biology
    Human Melanoma Metastases Express Functional CXCR4
    Stefania Scala, Paola Giuliano, Paolo A. Ascierto, Caterina Ieranò, Renato Franco, Maria Napolitano, Alessandro Ottaiano, Maria L. Lombardi, Monica Luongo, Ester Simeone, Daniele Castiglia, Francesca Mauro, Ileana De Michele, Rosa Calemma, Gerardo Botti, Corrado Caracò, Gianfranco Nicoletti, Rocco A. Satriano and Giuseppe Castello
    Clin Cancer Res April 15 2006 12 (8) 2427-2433; DOI:10.1158/1078-0432.CCR-05-1940

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia
    Daniel Steinbach, Alexander Schramm, Angelika Eggert, Masanori Onda, Kristin Dawczynski, Andreas Rump, Ira Pastan, Susann Wittig, Nadine Pfaffendorf, Astrid Voigt, Felix Zintl and Bernd Gruhn
    Clin Cancer Res April 15 2006 12 (8) 2434-2441; DOI:10.1158/1078-0432.CCR-05-2552

  • Imaging, Diagnosis, Prognosis
    Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer
    Dan Tong, Klaus Czerwenka, Georg Heinze, Martin Ryffel, Eva Schuster, Armin Witt, Sepp Leodolter and Robert Zeillinger
    Clin Cancer Res April 15 2006 12 (8) 2442-2448; DOI:10.1158/1078-0432.CCR-05-0964

  • Imaging, Diagnosis, Prognosis
    Coexpression of Actin-Related Protein 2 and Wiskott-Aldrich Syndrome Family Verproline-Homologous Protein 2 in Adenocarcinoma of the Lung
    Seitaro Semba, Keiichi Iwaya, Jun Matsubayashi, Hiromi Serizawa, Hiroaki Kataba, Takashi Hirano, Harubumi Kato, Takeshi Matsuoka and Kiyoshi Mukai
    Clin Cancer Res April 15 2006 12 (8) 2449-2454; DOI:10.1158/1078-0432.CCR-05-2566

  • Imaging, Diagnosis, Prognosis
    High-Resolution Mapping of Tumor Redox Status by Magnetic Resonance Imaging Using Nitroxides as Redox-Sensitive Contrast Agents
    Ken-ichiro Matsumoto, Fuminori Hyodo, Atsuko Matsumoto, Alan P. Koretsky, Anastasia L. Sowers, James B. Mitchell and Murali C. Krishna
    Clin Cancer Res April 15 2006 12 (8) 2455-2462; DOI:10.1158/1078-0432.CCR-05-2747

  • Imaging, Diagnosis, Prognosis
    Measuring Tissue-Based Biomarkers by Immunochromatography Coupled with Reverse-Phase Lysate Microarray
    Martin J. Romeo, John Wunderlich, Lien Ngo, Steven A. Rosenberg, Seth M. Steinberg and David M. Berman
    Clin Cancer Res April 15 2006 12 (8) 2463-2467; DOI:10.1158/1078-0432.CCR-05-1479

  • Imaging, Diagnosis, Prognosis
    Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index
    Grace M. Callagy, Paul D. Pharoah, Sarah E. Pinder, Forrest D. Hsu, Torsten O. Nielsen, Joseph Ragaz, Ian O. Ellis, David Huntsman and Carlos Caldas
    Clin Cancer Res April 15 2006 12 (8) 2468-2475; DOI:10.1158/1078-0432.CCR-05-2719

  • Imaging, Diagnosis, Prognosis
    Weak Expression of Focal Adhesion Kinase (pp125FAK) in Patients with Cervical Cancer Is Associated with Poor Disease Outcome
    Boris Gabriel, Axel zur Hausen, Elmar Stickeler, Carola Dietz, Gerald Gitsch, Dagmar-C. Fischer, Jiri Bouda, Clemens Tempfer and Annette Hasenburg
    Clin Cancer Res April 15 2006 12 (8) 2476-2483; DOI:10.1158/1078-0432.CCR-05-1867

  • Imaging, Diagnosis, Prognosis
    A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non–Small Cell Lung Cancer Patients
    Liqiang Xi, Michael C. Coello, Virginia R. Litle, Siva Raja, William E. Gooding, Samuel A. Yousem, Talal El-Hefnawy, Rodney J. Landreneau, James D. Luketich and Tony E. Godfrey
    Clin Cancer Res April 15 2006 12 (8) 2484-2491; DOI:10.1158/1078-0432.CCR-05-2037

  • Imaging, Diagnosis, Prognosis
    Immunohistochemical and Genetic Evaluation of Deoxycytidine Kinase in Pancreatic Cancer: Relationship to Molecular Mechanisms of Gemcitabine Resistance and Survival
    Valeria Sebastiani, Francesca Ricci, Belen Rubio-Viquiera, Piotr Kulesza, Charles J. Yeo, Manuel Hidalgo, Alison Klein, Daniel Laheru and Christine A. Iacobuzio-Donahue
    Clin Cancer Res April 15 2006 12 (8) 2492-2497; DOI:10.1158/1078-0432.CCR-05-2655

  • Imaging, Diagnosis, Prognosis
    The Diagnostic Accuracy of Reverse Transcription-PCR Quantification of Cytokeratin mRNA in the Detection of Sentinel Lymph Node Invasion in Oral and Oropharyngeal Squamous Cell Carcinoma: A Comparison with Immunohistochemistry
    Renaud Garrel, Mathilde Dromard, Valérie Costes, Eric Barbotte, Frédéric Comte, Quentin Gardiner, César Cartier, Marc Makeieff, Louis Crampette, Bernard Guerrier and Nathalie Boulle
    Clin Cancer Res April 15 2006 12 (8) 2498-2505; DOI:10.1158/1078-0432.CCR-05-2136

  • Imaging, Diagnosis, Prognosis
    N-Acetylglucosaminyltransferase V and β1-6 Branching N-Linked Oligosaccharides Are Associated with Good Prognosis of Patients with Bladder Cancer
    Hirofumi Ishimura, Toshiko Takahashi, Hiroaki Nakagawa, Shin-Ichiro Nishimura, Yoichi Arai, Yohei Horikawa, Tomonori Habuchi, Eiji Miyoshi, Atsushi Kyan, Shigeru Hagisawa and Chikara Ohyama
    Clin Cancer Res April 15 2006 12 (8) 2506-2511; DOI:10.1158/1078-0432.CCR-05-1938

  • Imaging, Diagnosis, Prognosis
    Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma Patients
    Blenda C.K. Wong, K.C. Allen Chan, Anthony T.C. Chan, Sing-Fai Leung, Lisa Y.S. Chan, Katherine C.K. Chow and Y.M. Dennis Lo
    Clin Cancer Res April 15 2006 12 (8) 2512-2516; DOI:10.1158/1078-0432.CCR-05-2572

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis
    Stephen M. Hahn, Douglas L. Fraker, Rosemarie Mick, James Metz, Theresa M. Busch, Debbie Smith, Timothy Zhu, Carmen Rodriguez, Andreea Dimofte, Francis Spitz, Mary Putt, Stephen C. Rubin, Chandrakala Menon, Hsing-Wen Wang, Daniel Shin, Arjun Yodh and Eli Glatstein
    Clin Cancer Res April 15 2006 12 (8) 2517-2525; DOI:10.1158/1078-0432.CCR-05-1625

  • Cancer Therapy: Clinical
    Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma
    Kimberly R. Lindsey, Linda Gritz, Richard Sherry, Andrea Abati, Patricia A. Fetsch, Lisa C. Goldfeder, Monica I. Gonzales, Kimberly A. Zinnack, Linda Rogers-Freezer, Leah Haworth, Sharon A. Mavroukakis, Donald E. White, Seth M. Steinberg, Nicholas P. Restifo, Dennis L. Panicali, Steven A. Rosenberg and Suzanne L. Topalian
    Clin Cancer Res April 15 2006 12 (8) 2526-2537; DOI:10.1158/1078-0432.CCR-05-2061

  • Cancer Therapy: Clinical
    Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation
    Sae-Won Han, Tae-You Kim, Yoon Kyung Jeon, Pil Gyu Hwang, Seock-Ah Im, Kyung-Hun Lee, Jee Hyun Kim, Dong-Wan Kim, Dae Seog Heo, Noe Kyeong Kim, Doo Hyun Chung and Yung-Jue Bang
    Clin Cancer Res April 15 2006 12 (8) 2538-2544; DOI:10.1158/1078-0432.CCR-05-2845

  • Cancer Therapy: Clinical
    Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer
    Sambasivarao Damaraju, David Murray, Jennifer Dufour, Diana Carandang, Sten Myrehaug, Gino Fallone, Colin Field, Russell Greiner, John Hanson, Carol E. Cass and Matthew Parliament
    Clin Cancer Res April 15 2006 12 (8) 2545-2554; DOI:10.1158/1078-0432.CCR-05-2703

  • Cancer Therapy: Clinical
    A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization
    Scott A. Laurie, John C. Bell, Harold L. Atkins, Joanne Roach, Michael K. Bamat, James D. O'Neil, M. Scot Roberts, William S. Groene and Robert M. Lorence
    Clin Cancer Res April 15 2006 12 (8) 2555-2562; DOI:10.1158/1078-0432.CCR-05-2038

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer
    Kelvin Hong, Afsheen Khwaja, Eleni Liapi, Michael S. Torbenson, Cristos S. Georgiades and Jean-Francois H. Geschwind
    Clin Cancer Res April 15 2006 12 (8) 2563-2567; DOI:10.1158/1078-0432.CCR-05-2225

  • Cancer Therapy: Preclinical
    Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy
    Hisashi Saji, Wenru Song, Katsuyoshi Furumoto, Harubumi Kato and Edgar G. Engleman
    Clin Cancer Res April 15 2006 12 (8) 2568-2574; DOI:10.1158/1078-0432.CCR-05-1986

  • Cancer Therapy: Preclinical
    Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin
    Enrica Balza, Lorenzo Mortara, Francesca Sassi, Stefano Monteghirfo, Barbara Carnemolla, Patrizia Castellani, Dario Neri, Roberto S. Accolla, Luciano Zardi and Laura Borsi
    Clin Cancer Res April 15 2006 12 (8) 2575-2582; DOI:10.1158/1078-0432.CCR-05-2448

  • Cancer Therapy: Preclinical
    A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non–Hodgkin's Lymphoma Cell Proliferation In vitro and In vivo
    Andrew C. Cooper, Russell M. Karp, Edward J. Clark, Nazbeh R. Taghizadeh, Jennifer G. Hoyt, Matthew T. Labenski, Michael J. Murray, Gerhard Hannig, William F. Westlin and Charles D. Thompson
    Clin Cancer Res April 15 2006 12 (8) 2583-2590; DOI:10.1158/1078-0432.CCR-05-0871

  • Cancer Therapy: Preclinical
    Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
    Dangshe Ma, Christine E. Hopf, Andrew D. Malewicz, Gerald P. Donovan, Peter D. Senter, William F. Goeckeler, Paul J. Maddon and William C. Olson
    Clin Cancer Res April 15 2006 12 (8) 2591-2596; DOI:10.1158/1078-0432.CCR-05-2107

  • Cancer Therapy: Preclinical
    Potential and Toxicity of Intravesical Pemetrexed: a Preclinical Study in Pigs
    Kees Hendricksen, Paula M.J. Moonen, Antoine G. van der Heijden, Janneke Molkenboer-Kuenen, Christina A. Hulsbergen-van de Kaa and J. Alfred Witjes
    Clin Cancer Res April 15 2006 12 (8) 2597-2601; DOI:10.1158/1078-0432.CCR-05-2644

  • Cancer Therapy: Preclinical
    The Bisphosphonate Olpadronate Inhibits Skeletal Prostate Cancer Progression in a Green Fluorescent Protein Nude Mouse Model
    Meng Yang, Doug W. Burton, Jack Geller, Darren J. Hillegonds, Randolph H. Hastings, Leonard J. Deftos and Robert M. Hoffman
    Clin Cancer Res April 15 2006 12 (8) 2602-2606; DOI:10.1158/1078-0432.CCR-05-2050

  • Cancer Therapy: Preclinical
    Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity
    Roberto Bianchi, Michael Brines, Giuseppe Lauria, Costanza Savino, Alessandra Gilardini, Gabriella Nicolini, Virginia Rodriguez-Menendez, Norberto Oggioni, Annalisa Canta, Paola Penza, Raffaella Lombardi, Claudio Minoia, Anna Ronchi, Anthony Cerami, Pietro Ghezzi and Guido Cavaletti
    Clin Cancer Res April 15 2006 12 (8) 2607-2612; DOI:10.1158/1078-0432.CCR-05-2177

  • Cancer Therapy: Preclinical
    Rapamycin Inhibits Growth of Premalignant and Malignant Mammary Lesions in a Mouse Model of Ductal Carcinoma In situ
    Ruria Namba, Lawrence J.T. Young, Craig K. Abbey, Lisa Kim, Patrizia Damonte, Alexander D. Borowsky, Jinyi Qi, Clifford G. Tepper, Carol L. MacLeod, Robert D. Cardiff and Jeffrey P. Gregg
    Clin Cancer Res April 15 2006 12 (8) 2613-2621; DOI:10.1158/1078-0432.CCR-05-2170

  • Cancer Therapy: Preclinical
    Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate
    Hans Prenen, Jan Cools, Nicole Mentens, Cedric Folens, Raf Sciot, Patrick Schöffski, Allan Van Oosterom, Peter Marynen and Maria Debiec-Rychter
    Clin Cancer Res April 15 2006 12 (8) 2622-2627; DOI:10.1158/1078-0432.CCR-05-2275

  • Cancer Therapy: Preclinical
    Roles of Nitric Oxide Synthase Inhibition and Vascular Endothelial Growth Factor Receptor-2 Inhibition on Vascular Morphology and Function in an In vivo Model of Pancreatic Cancer
    E. Ramsay Camp, Anthony Yang, Wenbiao Liu, Fan Fan, Ray Somcio, Daniel J. Hicklin and Lee M. Ellis
    Clin Cancer Res April 15 2006 12 (8) 2628-2633; DOI:10.1158/1078-0432.CCR-05-2257

  • Cancer Therapy: Preclinical
    Evaluation of Antitumoral Properties of the Protease Inhibitor Indinavir in a Murine Model of Hepatocarcinoma
    Vincenzo Esposito, Emanuele Palescandolo, Enrico P. Spugnini, Vincenzo Montesarchio, Antonio De Luca, Irene Cardillo, Giancarlo Cortese, Alfonso Baldi and Antonio Chirianni
    Clin Cancer Res April 15 2006 12 (8) 2634-2639; DOI:10.1158/1078-0432.CCR-05-2188

  • Cancer Therapy: Preclinical
    Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs
    Tom M. Ganten, Ronald Koschny, Jaromir Sykora, Henning Schulze-Bergkamen, Peter Büchler, Tobias L. Haas, Manuela B. Schader, Andreas Untergasser, Wolfgang Stremmel and Henning Walczak
    Clin Cancer Res April 15 2006 12 (8) 2640-2646; DOI:10.1158/1078-0432.CCR-05-2635

Obituary

  • Obituary
    John Robert Murren, M.D.: In Memoriam
    Clin Cancer Res April 15 2006 12 (8) 2647-2647; DOI:10.1158/1078-0432.CCR-06-0313

Letters to the Editor

  • Letters to the Editor
    Impact of Blood Sampling on Circulating Tissue Inhibitors of Metalloproteinases
    Klaus Jung
    Clin Cancer Res April 15 2006 12 (8) 2648-2648; DOI:10.1158/1078-0432.CCR-05-1592

  • Letters to the Editor
    Reply to the Letter to the Editor from Jung
    Henni Ruokolainen and Taina Turpeenniemi-Hujanen
    Clin Cancer Res April 15 2006 12 (8) 2648-2648; DOI:10.1158/1078-0432.CCR-05-2435

  • Letters to the Editor
    Comments on Plasmalemmal Vesicle Associated Protein-1 as a Novel Marker Implicated in Brain Tumor Angiogenesis
    Laura A. Sanders (Strickland) and Hartmut Koeppen
    Clin Cancer Res April 15 2006 12 (8) 2649-2649; DOI:10.1158/1078-0432.CCR-05-2624

  • Letters to the Editor
    Reply to the Letter to the Editor from Sanders et al
    Eleanor B. Carson-Walter and Kevin A. Walter
    Clin Cancer Res April 15 2006 12 (8) 2649-2649; DOI:10.1158/1078-0432.CCR-06-0287

Back to top
PreviousNext
Clinical Cancer Research: 12 (8)
April 2006
Volume 12, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate
  • A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis
  • New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer
  • Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity

Jump to

  • The Biology Behind
  • Molecular Pathways
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Obituary
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement